Risk of Cervical Abnormalities in Women With Inflammatory Bowel Disease: A Population-Based Nested Case-Control Study

Gastroenterology

Volumn 136, Issue 2, 2009, Pages 451-458

  Singh, Harminder ^a   Demers, Alain A ^a,b   Nugent, Zoann ^b   Mahmud, Salaheddin M ^a,b   Kliewer, Erich V ^a,b   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANADA; CANCER RISK; CANCER SCREENING; CANCER STAGING; CONTROL GROUP; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DRUG EXPOSURE; ENTERITIS; FEMALE; HEALTH CARE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MONOTHERAPY; ORAL CONTRACEPTION; PAPANICOLAOU TEST; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SOCIAL STATUS; ULCERATIVE COLITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 58949091573     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.10.021     Document Type: Article

References (39)

1. Steben M., and Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107 (2007) S2-S5
2. Seshadri L., George S.S., Vasudevan B., et al. Cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipients. Indian J Cancer 38 (2001) 92-95
3. Tam L.S., Chan A.Y., Chan P.K., et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 50 (2004) 3619-3625
4. Malouf M.A., Hopkins P.M., Singleton L., et al. Sexual health issues after lung transplantation: importance of cervical screening. J Heart Lung Transplant 23 (2004) 894-897
5. Kane S., Khatibi B., and Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol 103 (2008) 631-636
6. Bhatia J., Bratcher J., Korelitz B., et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol 12 (2006) 6167-6171
7. Venkatesan T., Beaulieu D.B., Ferrer V., et al. Abnormal pap smear, cervical dysplasia and immunomodulator therapy in women with inflammatory bowel disease (IBD). Gastroenterology 130 Suppl 2 (2006) A-3
8. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001) 854-862
9. ACOG practice bulletin. Cervical cytology screening. Number 45, August 2003. Int J Gynaecol Obstet 83 (2003) 237-247
10. Manitoba Cervical Cancer Screening Program. Management guidelines (2008), CancerCare Manitoba, Winnipeg
11. Zimet G.D., Shew M.L., and Kahn J.A. Appropriate use of cervical cancer vaccine. Annu Rev Med 59 (2008) 223-236
12. Solomon D., Davey D., Kurman R., et al., Forum Group Members and the Bethesda. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
13. In: Hotes Ellison J., Wu X.C., McLaughlin C., et al. (Eds). Cancer in North America: 1999-2003 Volume 1 (2006), North American Association of Central Cancer Registries Inc, Sacramento, CA II-325 Incidence
14. Bernstein C.N., Blanchard J.F., Rawsthorne P., et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 149 (1999) 916-924
15. Robinson J.R., Young T.K., Roos L.L., et al. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care 35 (1997) 932-947
16. Roos L.L., Mustard C.A., Nicol J.P., et al. Registries and administrative data: organization and accuracy. Med Care 31 (1993) 201-212
17. Kozyrskyj A.L., and Mustard C.A. Validation of an electronic, population-based prescription database. Ann Pharmacother 32 (1998) 1152-1157
18. Martens P.J., Frohlich N., Carriere K.C., et al. Embedding child health within a framework of regional health: population health status and sociodemographic indicators. Can J Public Health 93 Suppl 2 (2002) S15-S20
19. Martens P.J., Derksen S., and Gupta S. Predictors of hospital readmission of Manitoba newborns within six weeks postbirth discharge: a population-based study. Pediatrics 114 (2004) 708-713
20. Frohlich N., and Mustard C. A regional comparison of socioeconomic and health indices in a Canadian province. Soc Sci Med 42 (1996) 1273-1281
21. Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 15 (2006) 291-303
22. Castle P.E., and Giuliano A.R. Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 31 (2003) 29-34
23. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
24. Franco E.L., Rohan T.E., and Villa L.L. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91 (1999) 506-511
25. Cosnes J., Nion-Larmurier I., Beaugerie L., et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54 (2005) 237-241
26. Rambout L., Hopkins L., Hutton B., et al. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 177 (2007) 469-479
27. Jacobsen B.A., Fallingborg J., Rasmussen H.H., et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 18 (2006) 601-606
28. Selby L., Kane S., Wilson J., et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis 14 (2008) 253-258
29. Castellsague X., and Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31 (2003) 20-28
30. Bosch F.X., and de S.S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23 (2007) 213-227
31. Moody G., Probert C.S., Srivastava E.M., et al. Sexual dysfunction amongst women with Crohn's disease: a hidden problem. Digestion 52 (1992) 179-183
32. Timmer A., Bauer A., Dignass A., et al. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 5 (2007) 87-94
33. Saldivar J.S., Lopez D., Feldman R.A., et al. COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study. Gynecol Oncol 107 (2007) S155-S162
34. Sorensen H.T., Friis S., Norgard B., et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88 (2003) 1687-1692
35. Essebag V., Platt R.W., Abrahamowicz M., et al. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 5 (2005) 5
36. Etminan M. Pharmacoepidemiology II: the nested case-control study-a novel approach in pharmacoepidemiologic research. Pharmacotherapy 24 (2004) 1105-1109
37. Franco E.L., Duarte-Franco E., and Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164 (2001) 1017-1025
38. Pomerleau J., Pederson L.L., Ostbye T., et al. Health behaviours and socio-economic status in Ontario, Canada. Eur J Epidemiol 13 (1997) 613-622
39. Franco E.L., Schlecht N.F., and Saslow D. The epidemiology of cervical cancer. Cancer J 9 (2003) 348-359